Featured Research

from universities, journals, and other organizations

Injecting Autologous Cells Could Relieve Urinary Incontinence

Date:
July 9, 2007
Source:
The Lancet
Summary:
Transurethral injections of autologous myoblasts and fibroblasts could relieve stress urinary incontinence in women, conclude authors of a recent article published in The Lancet. Myoblasts are a type of muscle stem cell, while fibroblasts are cells which form the structural framework for many tissues in the body.

Transurethral injections of autologous myoblasts and fibroblasts could relieve stress urinary incontinence in women, conclude authors of an Article published in The Lancet. And an accompanying comment hails the development as the beginning of a new era in urogynaecology.

Myoblasts are a type of muscle stem cell, while fibroblasts are cells which form the structural framework for many tissues in the body. Autologous cells are ones which the patient is the source of.

Dr Hannes Strasser, Medical University of Innsbruck, Austria, and colleagues studied 63 women with stress urinary incontinence, of which 42 were given myoblast/fibroblast injections and 21 were given conventional endoscopic injections of collagen. All the women were given incontinence scores from 0-6, based on a 24-hour voiding diary, 24-hour pad test and a patient questionnaire. After 12 months, the contractibility of the rhabadosphincter (the muscle responsible for contraction of the urethra) and the thickness of the urethra were analysed.

The researchers found that 38 of the 42 women given the autologous cell injections were completely continent after 12 months, compared with just two of the 21 patients given conventional collagen treatment. The mean thickness of the rhabadosphincter increased by 59% in patients given autologus cell injections, compared to a 9% increase in the collagen-injection group; and the contractibility of the rhabadosphincter increased by 268% in patients given the autologous cell injections, compared with 15% in the collagen-injected group. The change in thickness of the urethra did not differ significantly between the two groups.

The authors say their data accord with other results that suggest success rates for injection of bulking agents such as collagen to treat urinary incontinence are poor. They say: “We show that continence improved more in patients injected with autologous myoblasts and fibroblasts than in those injected with collagen.”

They conclude: “Long-term postoperative results and data from multicentre trials with larger numbers of patients are needed to assess whether injection of autologous cells into the rhabadosphincter and the urethra could become a standard treatment for urinary incontinence.”

In the accompanying Comment, Dr Giacomo Novara and Dr Walter Artibani, Urology Clinic, University of Padua, Italy, say: “Hannes Strasser and colleagues report a randomised trial that can be seen as the beginning of a new era in urogynaecology.”

They conclude: “If the data are confirmed, this approach is likely to cause a substantial change in the treatment of female stress urinary incontinence, and could become one of the most important innovations in urology since the development of extracorporeal shockwave lithotripsy for urinary stone treatment and tension-free vaginal tape for stress urinary incontinence.”


Story Source:

The above story is based on materials provided by The Lancet. Note: Materials may be edited for content and length.


Cite This Page:

The Lancet. "Injecting Autologous Cells Could Relieve Urinary Incontinence." ScienceDaily. ScienceDaily, 9 July 2007. <www.sciencedaily.com/releases/2007/07/070706145526.htm>.
The Lancet. (2007, July 9). Injecting Autologous Cells Could Relieve Urinary Incontinence. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2007/07/070706145526.htm
The Lancet. "Injecting Autologous Cells Could Relieve Urinary Incontinence." ScienceDaily. www.sciencedaily.com/releases/2007/07/070706145526.htm (accessed September 22, 2014).

Share This



More Health & Medicine News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins